A hidden bat virus is infecting humans

When a deadly strain of avian influenza reached the remote Crozet Islands in 2024, the first victims were southern elephant seal pups. But a small group of king penguin chicks had something unusual on their side — they had already been vaccinated.

Deep in the sub-Antarctic, disease ecologist Thierry Boulinier and his team were in the final stages of a vaccine trial when the H5N1 virus arrived. Their goal was simple but ambitious: to see whether immunization could protect vulnerable wildlife from emerging global diseases.

After witnessing how bird flu swept across continents in 2022, killing countless birds and mammals, Boulinier says the threat was impossible to ignore. “Vaccination could become a way to safeguard species that are already on the brink,” he explains.

A Growing Role for Vaccines in Conservation

The penguin trial is just one part of a broader movement in conservation science. Around the world, researchers are increasingly turning to vaccines to combat diseases that threaten endangered animals.

In Australia, a vaccine for chlamydia in koalas was approved for wild use in 2023. Zoos are testing vaccines against a deadly herpesvirus in elephants, and in the United States, scientists are immunizing bats against white-nose syndrome, a fungal disease that has wiped out millions of individuals.

According to wildlife biologist Tonie Rocke from the U.S. Geological Survey, vaccines are becoming essential as animals are forced into closer contact by habitat loss and climate change. “Diseases are now spreading faster and farther than ever before,” she says.

Still, vaccines are not a perfect solution. They can be costly, difficult to distribute, and logistically challenging to deliver in remote ecosystems. But researchers agree they may offer one of the most powerful tools for preventing extinction.

Penguins and the Fight Against Bird Flu

Bird flu first appeared in the Antarctic region in late 2023. By the following year, it had traveled thousands of kilometers to the Crozet Islands, killing seals, albatrosses, skuas, and hundreds of king penguins.

In early 2024, Boulinier’s team vaccinated 30 king penguin chicks, followed by booster doses. The results were encouraging: the birds developed immune responses with no serious side effects.

Although none of the vaccinated penguins became infected during the outbreak, scientists still cannot confirm how effective the vaccine truly is. The two-dose requirement also makes large-scale vaccination difficult. Even so, new trials are now underway using single doses and adult penguins to test long-term protection.

Similar experiments have already shown promise in species like California condors, kākāpōs, and even marine mammals such as elephant seals and Hawaiian monk seals. “So far, the results have been surprisingly positive,” says veterinary epidemiologist Dominic Travis.

Koalas and a Breakthrough Against Chlamydia

For koalas, disease is only one piece of a larger survival crisis. Habitat destruction, heat waves, and stress all weaken their immune systems, making infections more severe.

Chlamydia causes blindness and infertility in koalas, and traditional antibiotic treatments often do more harm than good by destroying the gut bacteria they need to digest eucalyptus leaves.

The new vaccine aims to prevent severe infection altogether. While it is not perfect, studies show it reduces koala mortality by over 60 percent.

Delivering the vaccine in the wild, however, is no easy task. Koalas live high in trees, in rough terrain that is difficult to access. Locating them requires teams of researchers, tracking dogs, drones, and significant funding.

Even so, scientists see the vaccine as a major step forward. “It gives them a fighting chance,” says molecular biologist Nina Pollak.

Protecting Young Elephants from a Silent Killer

Another deadly disease threatens young elephants: elephant endotheliotropic herpesvirus (EEHV). This virus kills up to 85 percent of calves that develop severe symptoms, making it one of the leading causes of death in young Asian elephants.

In 2024, two elephants at the Cincinnati Zoo were naturally exposed to the virus after being vaccinated. Both survived with only mild symptoms — the first real-world evidence that the vaccine may work.

Researchers believe calves are most vulnerable once they lose protective antibodies passed down from their mothers. A vaccine could train their immune systems before the virus becomes overwhelming.

While still in early stages, scientists hope this vaccine could eventually protect wild elephant populations, not just those in captivity.

A Ray of Hope for Endangered Bats

In North America, a fungal disease called white-nose syndrome has devastated bat populations for nearly two decades. The fungus disrupts hibernation, causing bats to burn through their fat reserves and starve before spring.

Now, an experimental oral vaccine is offering new hope. Since 2019, researchers have vaccinated thousands of bats across the western United States, including endangered northern long-eared bats.

Early data suggests vaccinated bats are less likely to develop severe infections or die. For Tonie Rocke and her team, the success is remarkable. “There aren’t even fungal vaccines for humans yet,” she says.

With western bat populations particularly fragile, scientists believe vaccination could be the difference between survival and extinction for some species.

A New Frontier in Wildlife Protection

From penguins and koalas to elephants and bats, vaccines are slowly reshaping how scientists approach conservation. They are not miracle cures, but they offer something powerful: time.

Time for populations to recover.
Time for ecosystems to stabilize.
And time for humans to rethink how deeply our actions influence the health of the natural world.

As Rocke puts it, “Sometimes intervention is necessary. If we want these species to survive, we have to use every ethical tool available — and vaccines are becoming one of the most important.”